InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Lennon David James. Insider active across 2 companies, notably Aadi Bioscience, Inc.. In total, 9 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €897k. Activity tracked since 2 October 2024. The latest transaction was filed on 9 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Lennon David James is chief executive officer at Whitehawk Therapeutics, Inc. and Aadi Bioscience, Inc. He has 9 filings in total, and across the 9 sampled recent filings between 2024-10-03 and 2026-04-10, the modal transaction nature is Sale, with EUR 896927 in sales and EUR 0 in purchases.